Test Code HCT Hematocrit
Additional Codes
LAB289
Performing Laboratory
Central Peninsula Hospital
Collection Method
Venipuncture
Container
Purple Top EDTA
Specimen Type
EDTA Whole Blood
Minimum Volume
1ml
Specimen Stability
| Ambient | 24 hours |
| Refrigerated (4°C to 8°C) | 48 Hours |
| Frozen(-70°C to 0°C) | N/A |
Reference or Target Ranges
| TEST (Units) | AGE | NORMAL VALUE | SEX |
|
HEMATOCRIT (%) |
0D-1D |
40.5-58.5 |
MALE AND FEMALE |
|
|
1D-3D |
43.5-67.5 |
MALE AND FEMALE |
|
|
3D-7D |
40.5-64.5 |
MALE AND FEMALE |
|
|
7D-14D |
37.5-61.5 |
MALE AND FEMALE |
|
|
14D-30D |
30.0-54.0 |
MALE AND FEMALE |
|
|
30D-2MO |
27.0-42.0 |
MALE AND FEMALE |
|
|
2MO-6MO |
28.5-40.5 |
MALE AND FEMALE |
|
|
6MO-6YR |
34.5-40.5 |
MALE AND FEMALE |
|
|
6YR-12YR |
34.5-46.5 |
MALE AND FEMALE |
|
|
12YR-18YR |
39.0-48.0 |
MALE AND FEMALE |
|
|
>18YR |
42.0-54.0 |
MALE |
|
|
>18YR |
36.0-48.0 |
FEMALE |
Reportable Units
Varies
Critical Value
| TEST (Units) | AGE | SEX | CRITICAL VALUES |
|
HEMATOCRIT (%) |
0D-1D |
MALE AND FEMALE |
>67.6 |
|
|
1D-3D |
MALE AND FEMALE |
>67.6 |
|
|
3D-7D |
MALE AND FEMALE |
<24 or >65 |
|
|
7D-14D |
MALE AND FEMALE | <24 or >65 |
|
|
14D-30D |
MALE AND FEMALE |
<24 or >60 |
|
|
30D-2MO |
MALE AND FEMALE |
<21 or >60 |
|
|
2MO-6MO |
MALE AND FEMALE | <21 or >60 |
|
|
6MO-6YR |
MALE AND FEMALE | <21 or >60 |
|
|
6YR-12YR |
MALE AND FEMALE | <21 or >60 |
|
|
12YR-18YR |
MALE AND FEMALE | <21 or >60 |
|
|
>18YR |
MALE |
<21 or >60 |
|
|
>18YR |
FEMALE |
<21 or >60 |
Reasons for Rejection
| Hemolysis Threshold | N/A |
| Icterus Threshold | N/A |
| Lipemia Threshold | N/A |
| Other | Clotted, QNS, contaminated, improperly labeled |
Performance Information
| Days and Time Performed | 24/7 |
| Expected Turn Around Time |
Stat: Within 1 hour of arrival to lab Routine: Within 4 hours of arrival to lab |
| Stat Availabilty | Yes |
| Stat Availabilty | Within 1 hour of arrival to lab |
| Performing Bench | CPH Hematology |
| Methodology/Method Description | Sysmex |
CPT Codes
85014
Last review/edit date
2025